Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation

Cancer Genetics and Cytogenetics

Volumn 201, Issue 2, 2010, Pages 94-101

  Kuo, Shou Jen ^a   Chen, Ming ^a   Ma, Gwo Chin ^b   Chen, Shou Tung ^c   Chang, Shun Ping ^d   Lin, Wen Yin ^e   Chen, Yen Chieh ^e   Lee, Tsung Hsien ^a   Lin, Ta Tsung ^a   Liu, Chin San ^f  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d TUNGHAI UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOCHONDRIAL DNA; PROTEIN P53;

ADULT; AGE; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SOMATIC MUTATION; TUMOR VOLUME;

EID: 77955249892     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.05.013     Document Type: Article

References (46)

1. Kellen E., Vansant G., Christiaens M.R., Neven P., Van Limbergen E. Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 2009, 114:13-22.
2. Seow A., Duffy S.W., McGee M.A., Lee J., Lee H.P. Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol 1996, 25:40-45.
3. Chen C.J., You S.L., Lin L.H., Hsu W.L., Yang Y.W. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 2002, 32(Suppl):S66-S81.
4. Theillet C., Lidereau R., Escot C., Hutzell P., Brunet M., Gest J., et al. Loss of a c-H- ras-1 allele and aggressive human primary breast carcinomas. Cancer Res 1986, 46:4776-4781.
5. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 1991, 253:49-53.
6. Mangues R., Kahn J.M., Seidman I., Pellicer A. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis. Cancer Res 1994, 54:6395-6401.
7. Tan D.J., Bai R.K., Wong L.J. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 2002, 62:972-976.
8. Tseng L.M., Yin P.H., Chi C.W., Hsu C.Y., Wu C.W., Lee L.M., et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 2006, 45:629-638.
9. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998, 20:291-293.
10. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000, 287:2017-2019.
11. Parrella P., Xiao Y., Fliss M., Sanchez-Cespedes M., Mazzarelli P., Rinaldi M., et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 2001, 61:7623-7626.
12. Penta J.S., Johnson F.M., Wachsman J.T., Copeland W.C. Mitochondrial DNA in human malignancy. Mutat Res 2001, 488:119-133.
13. Zhu W., Qin W., Bradley P., Wessel A., Puckett C.L., Sauter E.R. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 2005, 26:145-152.
14. Clayton D.A., Davis R.W., Vinograd J. Homology and structural relationships between the dimeric and monomeric circular forms of mitochondrial DNA from human leukemic leukocytes. J Mol Biol 1970, 47:137-153.
15. Taira M., Yoshida E., Kobayashi M., Yaginuma K., Koike K. Tumor-associated mutations of rat mitochondrial transfer RNA genes. Nucleic Acids Res 1983, 11:1635-1643.
16. Bianchi M.S., Bianchi N.O., Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 1995, 71:99-103.
17. Suzuki M., Toyooka S., Miyajima K., Iizasa T., Fujisawa T., Bekele N.B., et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 2003, 9:5636-5641.
18. Wu C.W., Yin P.H., Hung W.Y., Li A.F., Li S.H., Chi C.W., et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 2005, 44:19-28.
19. Lee H.C., Li S.H., Lin J.C., Wu C.C., Yeh D.C., Wei Y.H. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 2004, 547:71-78.
20. Nomoto S., Yamashita K., Koshikawa K., Nakao A., Sidransky D. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 2002, 8:481-487.
21. Chen J.Z., Gokden N., Greene G.F., Mukunyadzi P., Kadlubar F.F. Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res 2002, 62:6470-6474.
22. Chen J.Z., Gokden N., Greene G.F., Green B., Kadlubar F.F. Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis 2003, 24:1481-1487.
23. Wang C.Y., Wang H.W., Yao Y.G., Kong Q.P., Zhang Y.P. Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 2007, 121:1253-1256.
24. Cavalli L.R., Liang B.C. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?. Mutat Res 1998, 398:19-26.
25. Tennis M., Krishnan S., Bonner M., Ambrosone C.B., Vena J.E., Moysich K., et al. p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 2006, 15:80-85.
26. Linderholm B., Lindh B., Tavelin B., Grankvist K., Henriksson R. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000, 89:51-62.
27. Gochhait S., Bhatt A., Sharma S., Singh Y.P., Gupta P., Bamezai R.N. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development: a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer 2008, 123:2580-2586.
28. Kang J.H., Kim S.J., Noh D.Y., Park I.A., Choe K.J., Yoo O.J., et al. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest 2001, 81:573-579.
29. Moriyama Y., Nishiguchi S., Tamori A., Koh N., Yano Y., Kubo S., et al. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma. Clin Cancer Res 2001, 7:1293-1298.
30. Moriya T., Kasajima A., Ishida K., Kariya Y., Akahira J., Endoh M., et al. New trends of immunohistochemistry for making differential diagnosis of breast lesions. Med Mol Morphol 2006, 39:8-13.
31. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
32. Alazzouzi H., Farriol M., Espin E., Armengol M., Pena M., Zeh K., et al. Molecular patterns of nuclear and mitochondrial microsatellite alterations in breast tumors. Oncol Rep 2003, 10:1561-1567.
33. Pavicic W.H., Laguens M., Richard S.M. Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer. Mol Med 2009, 15:160-165.
34. Chang S.C., Lin P.C., Yang S.H., Wang H.S., Liang W.Y., Lin J.K. Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis 2009, 24:623-628.
35. Sood A.K., Sorosky J.I., Dolan M., Anderson B., Buller R.E. Distant metastases in ovarian cancer: association with p53 mutations. Clin Cancer Res 1999, 5:2485-2490.
36. Rines R.D., van Orsouw N.J., Sigalas I., Li F.P., Eng C., Vijg J. Comprehensive mutational scanning of the p53 coding region by two-dimensional gene scanning. Carcinogenesis 1998, 19:979-984.
37. Rose S.L., Robertson A.D., Goodheart M.J., Smith B.J., DeYoung B.R., Buller R.E. The impact of p53 protein core domain structural alteration on ovarian cancer survival. Clin Cancer Res 2003, 9:4139-4144.
38. McIntyre J.F., Smith-Sorensen B., Friend S.H., Kassell J., Borresen A.L., Yan Y.X., et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994, 12:925-930.
39. Jia L.Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., et al. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 1997, 19:243-253.
40. Del Bo R., Bordoni A., Martinelli Boneschi F., Crimi M., Sciacco M., Bresolin N., et al. Evidence and age-related distribution of mtDNA D-loop point mutations in skeletal muscle from healthy subjects and mitochondrial patients. J Neurol Sci 2002, 202:85-91.
41. Alonso A., Martin P., Albarran C., Aquilera B., Garcia O., Guzman A., et al. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 1997, 18:682-685.
42. Hibi K., Nakayama H., Yamazaki T., Takase T., Taguchi M., Kasai Y., et al. Mitochondrial DNA alteration in esophageal cancer. Int J Cancer 2001, 92:319-321.
43. Liu V.W., Shi H.H., Cheung A.N., Chiu P.M., Leung T.W., Nagley P., et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001, 61:5998-6001.
44. Richard S.M., Bailliet G., Páez G.L., Bianchi M.S., Peltomäki P., Bianchi N.O. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 2000, 60:4231-4237.
45. Wang Y., Liu V.W., Ngan H.Y., Nagley P. Frequent occurrence of mitochondrial microsatellite instability in the D-loop region of human cancers. Ann N Y Acad Sci 2005, 1042:123-129.
46. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999, 23. 147-7.